ABSTRACT
A number of clinical studies have shown that the presence of tumor-infiltrating lymphocytes (TILs) in various types of cancer tissues is associated with improved outcome. 1, 2 Interest in TILs in breast cancer (BC) has rapidly gained momentum due to the accumulated studies showing that TILs play a role in tumor response to therapy in the adjuvant and neoadjuvant settings, particularly triple-negative (TNBC) and HER2+ types. [3] [4] [5] [6] [7] [8] Evaluating TILs has the potential to be introduced to clinical practice and clinical trials. Therefore, in 2014, a group of investigators with experience in this field met and published guidelines and recommendations on how to interpret and score TILs, 9 and standardized these recommendations in 2016. 10 The group was unable to publish clear recommendations on a few matters, including interobserver variability and tumor heterogeneity. Moreover, there were matters on which they made recommendations without supporting evidence, such as the sufficiency of scoring core needle biopsy (CNB) in patients treated in the neoadjuvant setting. This group recommended scoring stromal TILs even though they recognized intratumoral TILs might be more biologically relevant. 9 There have been a few studies addressing TILs heterogeneity 11 and interobserver variability as part of the validation process of the scoring in the clinical studies. [3] [4] [5] 12, 13 More recently, there have been a few studies specifically addressing the issue of interobserver variability. [14] [15] [16] Moreover, Buisseret et al 14 evaluated the accuracy of TILs score in CNB reflecting the full-face section (FFS), intraobserver variability, reliability of immunohistochemistry (IHC) compared to histochemistry of H&E, and reliability of digital pathology.
We sought to evaluate interobserver variability between two raters, explore tumor heterogeneity between two FFSs from the same tumor, and investigate if the CNB is a good representation of the FFS.
Materials and Methods

Cases
The inclusion criteria were (1) BC patients treated in the adjuvant setting; (2) H&E glass slides of at least two FFSs and the corresponding CNB were available for review; (3) an adequate tissue quality for pathologic assessment with at least 20% of tissue contain invasive tumor; and (4) the CNB contains minimal (<5%) component of ductal carcinoma in situ.
The following pathologic variables were recorded: histologic type, tumor size in the CNB and in the excision, number of CNBs involved with tumor, and Nottingham grade. The biomarkers statuses, estrogen receptor (ER), progesterone receptor (PR), and HER2 were abstracted from the pathology reports. ER and PR were scored following the Allred scoring system as previously described, with a score of greater than 2 considered positive.
17 HER2 was scored following American Society of Clinical Oncology-College of American Pathologists 2013 guidelines.
18
Tumor-Infiltrating Lymphocytes Scoring Systems
Two types of TILs were recognized, TIL-str and iTu-Ly. TIL-str was defined as TILs between nests of invasive carcinoma and at the invasive edge but not intratumoral. iTu-Ly was defined as TILs in direct cellcell contact with the carcinoma cells but not in the stromal compartment. TIL-str was scored following the International TILs Working Group 2014 by estimating the percentage of TILs in stroma ❚Image 1❚. 9 iTu-Ly was scored by estimating the percentage of the tumor that harbors lymphocytes, as previously described by Denkert et al and Loi et al. 4, 5, 12, 13 In all scoring systems neutrophils and eosinophils were not scored. Two pathologists independently and blinded to the scores of the other samples and to each other scored TILs (V.N. and T.K.).
Statistical Analysis
To measure the degree of agreement between the two raters, intraclass correlation coefficients (ICC) and squared weighted κ statistics were calculated based on their scores in different specimen settings (CNB, FFS1, FFS2, and FFS1/FFS2). Because many studies that correlated TILs with clinical outcomes used different cutoffs to divide the cases into classes, we used three sets of cutoffs, two trichotomous (0%, >0% to <60%, and ≥60%, and 0% to 10%, >10% to <50%, and ≥50%), and one dichotomous (0% to <60% and ≥60%). To measure the agreements of scores (FFS1 vs FFS2, and CNB vs average FFSs), three statistical methods were used. ICC was calculated between FFS1 vs FFS2 for the consistency of the measurements. Spearman correlation was calculated between CNB vs average FFSs for their association. Squared weighted κ statistics were calculated when the data were divided into three classes, as described above. Spearman correlation was also calculated to measure the association between TIL-str and iTu-Ly in different specimen types. Tests of significance were conducted for every statistic, including ICC, κ statistics, and spearman correlation, to test if they differ from 0. Weighted κ values were interpreted as follows: 0 to 0.2 = none to slight, 0.21 to 0.4 = fair, 0.41 to 0.6 = moderate, 0.61 to 0.8 = substantial, and 0.8 to 1 = almost perfect agreement. 19 All reported tests were conducted at a nominal significance level of 0.05. Statistical analysis was performed using R version 3.3.2 (http://www.r-project.org).
Results
Pathologic Data
There were 100 candidate cases distributed according to the clinical subtype as follows: 41 ER+/HER2-, 39 TNBC, and 20 HER2+. Invasive lobular carcinoma (n = 12) cases were exclusively of the ER+/HER2-subtype. There was no difference between the clinical subtypes with regards to size of the tumor in the CNB, number of involved CNB, or size of the tumor in the excision ❚Table 1❚. The range for TIL-str (average between two raters) was zero to 90, zero to 85, zero to 85, and zero to 85 for CNB, FFS1, FFS2, and average FFS1/FFS2, respectively. Image 1 shows examples of the percentage of TIL-str. The range for iTu-Ly (average between two raters) was zero to 100, zero to 100, zero to 100, and zero to 100 for CNB, FFS1, FFS2, and average FFS1/FFS2, respectively.
Interobserver Variability
For TIL-str, the weighted κ values for the interobserver agreement for CB, FFS1, and FFS2 was substantial (0.65, 0.71, and 0.66, respectively) and for average 10%, >10% to <50%, and ≥50% had the highest number of cases with disagreement between raters (Supplemental Figure 1 and Supplemental Tables 1 to 3 ; all supplemental materials can be found at American Journal of Clinical Pathology online). For iTu-Ly, the weighted κ values for the agreement for CB, FFS1, and FFS1/FFS2 between both raters were moderate (0.50, 0.58, and 0.53, respectively) and for FFS2 were substantial (0.63) ( Table 2 and ❚Figure 2❚). ICC was 0.88, 0.85, 0.81, and 0.86, respectively (P < .0001). Both of the trichotomous approaches had relatively higher numbers of cases with disagreement between raters than the dichotomous approach (Supplemental Figure 2) .
Tumor-Infiltrating Lymphocytes Heterogeneity Between Full-Face Sections
Evaluating heterogeneity between FFSs is useful when studying cases treated in the adjuvant setting. For TIL-str, the ICC was 0.91 ❚Figure 3A❚. For iTu-Ly, the ICC was 0.96 ❚Figure 3B❚. However, there were large differences in the number of cases belonging to different classes when cutoff 0% to 10%, >10% to <50%, and ≥50% was used compared to 0%, >0% to <60%, and ≥60% (Supplemental Figure 3 and Supplemental Tables 4 to 6).
Tumor-Infiltrating Lymphocytes Heterogeneity Between Core Needle Biopsy and Full-Face Sections
Evaluating heterogeneity between CNB and the average of FFSs is useful when studying cases treated in the neoadjuvant setting. For TIL-str, Spearman correlation coefficient was 0.81 ❚Figure 4A❚. The cutoff 0% to 10%, >10% to <50%, and ≥50% had the highest number of cases belonging to different classes (Supplemental Figure 4 and Supplemental Tables 4 to 6). For iTu-Ly, Spearman correlation coefficient was 0.79 ❚Figure 4B❚. The number of cases belonging to different classes was high regardless of the cutoffs used (Supplemental Figure 4) . One possible source for the disagreement between CNB and FFS is tumor heterogeneity where the biopsy samples an area not fully representative of the FFS, as seen in ❚Image 2❚. This scenario was seen in a single case in our study.
The multivariate linear regression analysis showed that CNB and average FFSs were still significantly correlated after adjusting for the number of CNBs and the size of the tumor in the CNBs (P < .0001). 
The Relationship Between TIL-str and iTu-Ly in Core Needle Biopsy and Full-Face Sections
Spearman correlation was calculated to measure the association between TIL-str and iTu-Ly. Spearman correlation for TIL-str and iTu-Ly was 0.74, 0.65, 0.71, and 0.72 in CNB, FFS1, FFS2, and average FFS1/FFS2, respectively ❚Figure 5❚.
Discussion
In this study we reviewed three sets of BC cases (n = 100), one set of CNB, and two sets of corresponding excisional biopsy FFSs. TIL-str and iTu-Ly were scored by two raters. We evaluated the interobserver variabilities for all samples and for both scoring methods. We also evaluated tumor heterogeneity between samples. The agreement between the raters ranged from moderate to substantial in all types of samples and in both scoring methods. The same findings were appreciated when evaluating tumor heterogeneity between FFSs. The only substantial variation found was for iTu-Ly between CNB and average FFSs.
Although it is generally acceptable to score TILs in the stroma, as suggested by the international working group, recent data revealed significant differences when the analysis was restricted to the assessment of TILs based on their location. 20 It has been suggested that not only stromal TILs are clinically significant but also iTu-Ly, as described by us, 3 and in the peritumoral stroma. 20 This observation has been further supported by quantitative studies utilizing T-cell markers. 21, 22 Therefore, this study should be interpreted with caution, as we have only scored stromal TILs and iTu-Ly.
A number of studies specifically investigated the interobserver variability for BC TILs. [14] [15] [16] In Buisseret et al, 14 two pathologists independently scored global iTu-Ly and TIL-str, as well as tertiary lymphoid structures on glass slides of FFS in 124 BC cases. The concordance correlation coefficient values were 0.72, 0.57, and 0.69, respectively. These values improved dramatically when using IHC, to 0.80, 0.72, and 0.71, respectively. 
A B
❚Figure 4❚ Scattered plots showing the correlation between core needle biopsy (CNB) and average full-face section 1/2 (FFS1/ FFS2) in terms of tumor-infiltrating stromal lymphocytes (TIL-str) (A) and intratumoral lymphocytes (iTu-Ly) (B).
We followed similar guidelines in scoring TIL-str, which were scored by two raters as well. We have fairly similar results, as the agreement between the two raters was 0.53 for the average FFSs, 0.71 for FFS1, and 0.66 for FFS2. Tramm et al 15 scored TIL-str on FFSs of 124 BC cases with varying histology, tumor grade, and ER and HER2 status. Nine pathologists independently scored the scanned images (×20 magnification) of H&E-stained slides. κ values ranged from 0.38 to 0.46. When the data were divided into four categories, the κ values ranged from 0.36 to 0.48. When the data were divided into three categories using two sets of cutoffs, the κ values improved to 0.79 and 0.82, respectively. Finally, when the data were divided into two categories using 50% and 60% cutoff, the agreement increased substantially to 0.93 and 0.95, respectively. However, the vast majority of cases had low TILs. Because the study of Tramm et al 15 had more than two raters, it was difficult to compare our results to theirs. However, when we divided the data into three classes, the agreement between the two raters improved with κ values for FFS1, FFS2, and FFS1/FFS2 of 0.79, 0.61, and 0.78, respectively. In the study of Swisher et al, 16 four pathologists independently scored TIL-str and iTu-Ly on H&E-stained slides obtained from 75 TNBC CNBs. They divided the data into three classes using two cutoffs (10% and 50%). κ value for TIL-str was 0.57. For iTu-Ly, ❚Image 2❚ An example of the source of discordance between core needle biopsy (CNB) and excisional biopsy. A, Tumorinfiltrating stromal lymphocytes (TIL-str) score in the CNB is 10% (×5) . B, The arrows indicate the biopsy site with granulation tissue and fat necrosis (×2). C, The tissue next to the biopsy site also shows TIL-str 10% (corresponds to lower left box in B) (×5). D, Away from the biopsy site the tumor has 90% TIL-str (corresponds to upper right box in B) (×20).
ICC was calculated to determine the agreement among raters. ICC was 0.62 with confidence interval (CI) 0.50 to 0.7. 16 We noticed from analyzing the results of these three studies along with ours that two factors played major roles in the variation of the κ values and the agreements between the raters. These factors were the number of raters and the way of interpreting the data (continuous or binary using different cutoffs). When the number of raters increased, the κ values decreased. That is why, in part, the κ values were lower in Tramm et al 15 and Swisher et al 16 studies compared to ours and the study conducted by Buisseret et al. 14 When cutoffs were implemented in the data analysis, the κ values improved as seen in our study and others. 15, 16 Two additional studies conducted by Denkert et al 4, 12 and two by Loi et al 5, 13 had similar scoring systems and similar approach to the interobserver variability to our approach. They scored TIL-str by estimating the percentage of TILs in the stroma. Later, this approach was adopted by the International TILs Working Group. 9 They also scored iTu-Ly similar to our scoring system. Therefore, in this discussion we were able to compare directly these results. Denkert et al evaluated the interobserver variability between raters in CNB of BCs treated in the neoadjuvant setting. 4, 12 In the first study, they investigated the role of TILs in BC cases (n = 1,058). Similar to our approach, two pathologists independently scored the CNBs. Pearson correlation coefficient between the two raters was 0.83 for TIL-str and 0.87 for iTu-Ly when they treated the data as a continuous variable. The interobserver κ value for the categorical parameter (three subgroups, using a 60% cutoff) was 0.61. 12 In the second study, Denkert et al evaluated TILs in HER2+ and TNBC. Three pathologists evaluated a set of digital images of 87 regions of interest from 29 tumors. The scores were divided into two groups using 60% cutoff. The three raters were compared with one another. The κ values were 0.90, 0.69, and 0.60. For TIL-str, the ICC for the 29 cases and three raters was 0.83 to 0.96 for single measures and 0.93 to 0.99 for average measures. 4 These results were comparable to ours. In our study, interclass correlation coefficient was 0.91 for TIL-str and 0.88 for iTu-Ly. κ values were 0.65 for TIL-str and 0.62 for iTu-Ly.
All these studies followed the International TILs Working Group 2014 guidelines in scoring TILs (stromal and intratumoral). Although they all found disagreement between raters with varying degrees, we believe that the degree of reproducibility was acceptable, particularly when the data were divided into classes using cutoffs.
Many studies that investigated the role of TILs in the clinical outcome and response to therapy divided the data using cutoffs. 4, 12, 23 Loi et al 13 evaluated TILs (both TIL-str and iTu-Ly) in two separate studies where the patients were treated in the adjuvant setting. In the BIG 02-98 clinical trial, two pathologists evaluated FFSs of 2,009 BC cases. Pearson correlation coefficient between the two raters was 0.71 for TIL-str and 0.49 for iTu-Ly when the data were treated as a continuous variable. When the data were treated as categorical variable (no infiltrate vs partial infiltrate vs lymphocytic predominant BC) using 50% as a cutoff, the interobserver κ value was 0.57. 13 In the FinHER trial, two pathologists reviewed FFSs of HER2+ BC cases (n = 1,010). The correlation coefficient between the two raters was 0.77 for TIL-str and 0.49 for iTu-Ly. They included only TIL-str in the survival analysis because the agreement between the two raters for iTu-Ly was low. 13 In our study, κ values were moderate to substantial for both TILs compartments in various FFS comparisons. When the data were divided into three classes, the κ values became substantial to almost perfect.
To our knowledge, we are the first to evaluate the degree of heterogeneity between two FFSs from surgical excisions. We found that the degree of heterogeneity between two FFSs was very low. Therefore, we recommend including a single slide of the tumor FFS for TILs evaluation in studies of BC treated in the adjuvant setting.
Denkert et al 10 performed an experiment where two sets of CNB slides, 60 cases each, were independently reviewed by 23 pathologists in two study rings. In ring study 1, the interclass correlation coefficient was 0.70 (95% CI, 0.62-0.78). Then, they developed a more advanced digital image evaluation system with feedback for ring study 2, which improved the interclass correlation coefficient to 0.89 (95% CI, 0.85-0.92). 10 Mani et al evaluated spatial heterogeneity of TILs in 26 BC samples. They took two to three 2-mm punch biopsies from each of the 33 BC tissue sections. They stained all samples with CD3, CD8, CD20, cytokeratin, and 4′,6-diamidino-2-phenylindole (DAPI) using a multiplexed quantitative immunofluorescence staining method. They measured the variation between different regions of the same section, and between biopsies of the same tumor. They found TILs to be more heterogeneous across the dimension of the same section, compared to the variation seen between samples taken from different regions. They concluded that the average lymphocyte score from a single biopsy of a tumor is reasonably representative of the whole cancer. 11 Buisseret et al 14 evaluated the accuracy of CNB as a reflection of primary tumor in 65 cases stained with CD45 and reviewed by three pathologists. They found marked linear dependence between the two measurements for global TILs with slight proportional underestimation effect that disappears as the TIL scores increase.
14 When we compared TIL-str scores between CNB and average FFSs, only 4% had heterogeneity between CNB and FFSs (Figure 2) . However, heterogeneity was more pronounced for iTu-Ly with 26% belonged to different classes when 0%, >0% to <60%, ≥60% cutoffs were used and 37% when ≤10%, >10% to <50%, ≥50% cutoffs were used. We found difficulty in recognizing lymphocytes in the CNBs due to crush artifact. This may explain why Buisseret et al 14 found less heterogeneity than us as they used IHC with CD45 to help recognize these cells. Therefore, we conclude that CNB is a good representation of full surgical section of the tumor when scoring TIL-str. When scoring iTu-Ly in CNB using H&E, caution should be exercised. It is possible that using IHC to identify intratumoral lymphocytes could improve the scoring and, therefore, the concordance between the CNB and the FFS.
The relationship between TIL-str and iTu-Ly was evaluated by Loi et al 13 who studied the role of TILs in BC treated in the adjuvant setting. They evaluated FFS of tumors and found the correlation between mean percentage TIL-str and iTu-Ly to be 0.648. 13 We had a fairly similar result for FFS1 (0.65) and slightly higher for FFS2 (0.71). Even though a high correlation between the lymphocytes located in the stroma (TIL-str) and those found embedded in the tumor cells (iTu-Ly) was found in our study, the difference might be biologically important. In a study conducted by us, we found that iTu-Ly but not TILstr had prognostic value in ER+/HER2-type BC treated with neoadjuvant therapy. 3 More studies comparing the prognostic role of TIL-str and iTu-Ly in various BC clinical subtypes are needed.
We conclude that TILs, like any morphologic variable in human tissue, are subject to interobserver variability and intratumor heterogeneity. However, we think the degree of agreement is acceptable, particularly when cutoffs are used. TILs heterogeneity between FFSs from surgical excisions is minimal. Therefore, when evaluating the role of TILs in BC treated in the adjuvant setting, we recommend scoring a single FFS. While the degree of TIL-str heterogeneity between CNB and FFS of surgical excision is low, iTu-Ly had a high degree of heterogeneity. Therefore, when evaluating the role of TILs in BC treated in the neoadjuvant setting, it is acceptable to score TILstr. On the other hand, if iTu-Ly is to be scored, caution must be exercised when evaluating H&E stained slides.
